Literature DB >> 24158360

Models of service delivery for cancer genetic risk assessment and counseling.

Angela M Trepanier1, Dawn C Allain.   

Abstract

Increasing awareness of and the potentially concomitant increasing demand for cancer genetic services is driving the need to explore more efficient models of service delivery. The aims of this study were to determine which service delivery models are most commonly used by genetic counselors, assess how often they are used, compare the efficiency of each model as well as impact on access to services, and investigate the perceived benefits and barriers of each. Full members of the NSGC Familial Cancer Special Interest Group who subscribe to its listserv were invited to participate in a web-based survey. Eligible respondents were asked which of ten defined service delivery models they use and specific questions related to aspects of model use. One-hundred ninety-two of the approximately 450 members of the listserv responded (42.7%); 177 (92.2%) had provided clinical service in the last year and were eligible to complete all sections of the survey. The four direct care models most commonly used were the (traditional) face-to-face pre- and post-test model (92.2%), the face-to-face pretest without face-to-face post-test model (86.5%), the post-test counseling only for complex results model (36.2%), and the post test counseling for all results model (18.3%). Those using the face-to-face pretest only, post-test all, and post-test complex models reported seeing more new patients than when they used the traditional model and these differences were statistically significantly. There were no significant differences in appointment wait times or distances traveled by patients when comparing use of the traditional model to the other three models. Respondents recognize that a benefit of using alternative service delivery models is increased access to services; however, some are concerned that this may affect quality of care.

Entities:  

Mesh:

Year:  2013        PMID: 24158360     DOI: 10.1007/s10897-013-9655-6

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  38 in total

1.  Knowledge and attitudes of gynecologists regarding genetic counseling for hereditary breast and ovarian cancer.

Authors:  Anja Mehnert; Corinna Bergelt; Uwe Koch
Journal:  Patient Educ Couns       Date:  2003-02

2.  Physician use of genetic testing for cancer susceptibility: results of a national survey.

Authors:  Louise Wideroff; Andrew N Freedman; Lorayn Olson; Carrie N Klabunde; William Davis; Kadaba P Srinath; Robert T Croyle; Rachel Ballard-Barbash
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2003-04       Impact factor: 4.254

3.  Barriers to and motivations for physician referral of patients to cancer genetics clinics.

Authors:  Carrie F Prochniak; Lisa J Martin; Erin M Miller; Sara C Knapke
Journal:  J Genet Couns       Date:  2011-08-13       Impact factor: 2.537

4.  Assessment and counseling for women with a family history of breast cancer. A guide for clinicians.

Authors:  K F Hoskins; J E Stopfer; K A Calzone; S D Merajver; T R Rebbeck; J E Garber; B L Weber
Journal:  JAMA       Date:  1995-02-15       Impact factor: 56.272

5.  Essential elements of genetic cancer risk assessment, counseling, and testing: updated recommendations of the National Society of Genetic Counselors.

Authors:  Bronson D Riley; Julie O Culver; Cécile Skrzynia; Leigha A Senter; June A Peters; Josephine W Costalas; Faith Callif-Daley; Sherry C Grumet; Katherine S Hunt; Rebecca S Nagy; Wendy C McKinnon; Nancie M Petrucelli; Robin L Bennett; Angela M Trepanier
Journal:  J Genet Couns       Date:  2011-12-02       Impact factor: 2.537

6.  Use of cancer susceptibility testing among primary care physicians.

Authors:  R Sifri; R Myers; T Hyslop; B Turner; J Cocroft; T Rothermel; J Grana; N Schlackman
Journal:  Clin Genet       Date:  2003-10       Impact factor: 4.438

7.  Genetic counseling for families with inherited susceptibility to breast and ovarian cancer.

Authors:  B B Biesecker; M Boehnke; K Calzone; D S Markel; J E Garber; F S Collins; B L Weber
Journal:  JAMA       Date:  1993-04-21       Impact factor: 56.272

8.  US physicians' attitudes toward genetic testing for cancer susceptibility.

Authors:  A N Freedman; L Wideroff; L Olson; W Davis; C Klabunde; K P Srinath; B B Reeve; R T Croyle; R Ballard-Barbash
Journal:  Am J Med Genet A       Date:  2003-07-01       Impact factor: 2.802

9.  Recommendations from the EGAPP Working Group: genetic testing strategies in newly diagnosed individuals with colorectal cancer aimed at reducing morbidity and mortality from Lynch syndrome in relatives.

Authors: 
Journal:  Genet Med       Date:  2009-01       Impact factor: 8.822

10.  Breast cancer risk communication: assessment of primary care physicians by standardized patients.

Authors:  Julie O Culver; Deborah J Bowen; Susan E Reynolds; Linda E Pinsky; Nancy Press; Wylie Burke
Journal:  Genet Med       Date:  2009-10       Impact factor: 8.822

View more
  30 in total

1.  Counselees' Perspectives of Genomic Counseling Following Online Receipt of Multiple Actionable Complex Disease and Pharmacogenomic Results: a Qualitative Research Study.

Authors:  Kevin Sweet; Shelly Hovick; Amy C Sturm; Tara Schmidlen; Erynn Gordon; Barbara Bernhardt; Lisa Wawak; Karen Wernke; Joseph McElroy; Laura Scheinfeldt; Amanda E Toland; J S Roberts; Michael Christman
Journal:  J Genet Couns       Date:  2016-12-05       Impact factor: 2.537

2.  "Where Does it Come from?" Experiences Among Survivors and Parents of Children with Retinoblastoma in Kenya.

Authors:  Amal Gedleh; Siwon Lee; Jessica A Hill; Yvonne Umukunda; Seemi Qaiser; Joy Kabiru; Kahaki Kimani; Lucy Njambi; Grace Kitonyi; Helen Dimaras
Journal:  J Genet Couns       Date:  2017-11-23       Impact factor: 2.537

Review 3.  Disparities in gynecologic cancer genetics evaluation.

Authors:  Emily M Hinchcliff; Erica M Bednar; Karen H Lu; J Alejandro Rauh-Hain
Journal:  Gynecol Oncol       Date:  2019-01-31       Impact factor: 5.482

4.  Outcomes of a Randomized Controlled Trial of Genomic Counseling for Patients Receiving Personalized and Actionable Complex Disease Reports.

Authors:  Kevin Sweet; Amy C Sturm; Tara Schmidlen; Joseph McElroy; Laura Scheinfeldt; Kandamurugu Manickam; Erynn S Gordon; Shelly Hovick; J Scott Roberts; Amanda Ewart Toland; Michael Christman
Journal:  J Genet Couns       Date:  2017-03-27       Impact factor: 2.537

5.  Interventions to improve patient access to and utilisation of genetic and genomic counselling services.

Authors:  Caroline M Benjamin; Lois H Thomas; Heather Skirton; Shanna Gustafson; Jacqueline Coupe; Christine Patch; Rachel Belk; Svetlana Tishkovskaya; Kathleen Calzone; Katherine Payne
Journal:  Cochrane Database Syst Rev       Date:  2015-11-17

6.  A prospective cohort study assessing clinical referral management & workforce allocation within a UK regional medical genetics service.

Authors:  Caroline Benjamin; Catherine Houghton; Claire Foo; Chris Edgar; Gail Mannion; Jan Birch; Ian Ellis; Astrid Weber
Journal:  Eur J Hum Genet       Date:  2015-03-11       Impact factor: 4.246

7.  Operationalizing the Reciprocal Engagement Model of Genetic Counseling Practice: a Framework for the Scalable Delivery of Genomic Counseling and Testing.

Authors:  Tara Schmidlen; Amy C Sturm; Shelly Hovick; Laura Scheinfeldt; J Scott Roberts; Lindsey Morr; Joseph McElroy; Amanda E Toland; Michael Christman; Julianne M O'Daniel; Erynn S Gordon; Barbara A Bernhardt; Kelly E Ormond; Kevin Sweet
Journal:  J Genet Couns       Date:  2018-02-19       Impact factor: 2.537

8.  Preferences for in-person disclosure: Patients declining telephone disclosure characteristics and outcomes in the multicenter Communication Of GENetic Test Results by Telephone study.

Authors:  Nina Beri; Linda J Patrick-Miller; Brian L Egleston; Michael J Hall; Susan M Domchek; Mary B Daly; Pamela Ganschow; Generosa Grana; Olufunmilayo I Olopade; Dominique Fetzer; Amanda Brandt; Rachelle Chambers; Dana F Clark; Andrea Forman; Rikki Gaber; Cassandra Gulden; Janice Horte; Jessica Long; Terra Lucas; Shreshtha Madaan; Kristin Mattie; Danielle McKenna; Susan Montgomery; Sarah Nielsen; Jacquelyn Powers; Kim Rainey; Christina Rybak; Michelle Savage; Christina Seelaus; Jessica Stoll; Jill E Stopfer; Xinxin Shirley Yao; Angela R Bradbury
Journal:  Clin Genet       Date:  2018-12-07       Impact factor: 4.438

9.  Experiences of Genetic Counselors Practicing in Rural Areas.

Authors:  Margaret Emmet; Quinn Stein; Erin Thorpe; MaryAnn Campion
Journal:  J Genet Couns       Date:  2017-08-22       Impact factor: 2.537

10.  Randomized Noninferiority Trial of Telephone vs In-Person Disclosure of Germline Cancer Genetic Test Results.

Authors:  Angela R Bradbury; Linda J Patrick-Miller; Brian L Egleston; Michael J Hall; Susan M Domchek; Mary B Daly; Pamela Ganschow; Generosa Grana; Olufunmilayo I Olopade; Dominique Fetzer; Amanda Brandt; Rachelle Chambers; Dana F Clark; Andrea Forman; Rikki Gaber; Cassandra Gulden; Janice Horte; Jessica M Long; Terra Lucas; Shreshtha Madaan; Kristin Mattie; Danielle McKenna; Susan Montgomery; Sarah Nielsen; Jacquelyn Powers; Kim Rainey; Christina Rybak; Michelle Savage; Christina Seelaus; Jessica Stoll; Jill E Stopfer; Xinxin Shirley Yao
Journal:  J Natl Cancer Inst       Date:  2018-09-01       Impact factor: 13.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.